Publications by authors named "F Lavainne"
Article Synopsis
- Diuretics might help reduce fluid overload in patients before starting dialysis, and this study explored their impact on delaying dialysis necessity, conditions at the start of dialysis, and early mortality.
- Researchers analyzed data from over 59,000 patients who started dialysis between 2009 and 2015, categorizing them based on their exposure to diuretics over the previous year.
- Results showed that those continuously using diuretics had fewer emergency dialysis starts, required fewer central venous catheters, experienced lower hospitalization rates, and potentially had lower mortality in the first three months after starting dialysis compared to those who stopped or never used diuretics.
Introduction: Incremental hemodialysis (iHD) may attenuate "dialysis shock" and reduce costs, preserving quality of life. It is considered difficult to reconcile with HD wards' routine; fear of underdialysis and increasing mortality are additional concerns. The aim of this study was to evaluate mortality, morbidity, and costs in a large HD ward where iHD is the standard of HD start.
View Article and Find Full Text PDF[Chronic kidney disease - Mineral bone disorders: Physiopathology and guidelines].
Rev Med Interne
April 2022
Chronic Kidney Disease (CKD) is associated with a strong impact on phosphocalcic homeostasis, due to the chronic reduction in glomerular filtration rate (GFR) (phosphate excretion decrease), the inhibition of calcitriol synthesis and dietary restrictions. CKD-Mineral and Bone Disorders (CKD-MBD) must be monitored in CKD patients with biological work-up associated with bone markers and bone density dual X-ray absorptiometry. Adapted diet (phosphate restriction, normalization of calcium intake) and medications (vitamin D, phosphate binders, calcimimetics) help to correct CKD-MBD.
View Article and Find Full Text PDFBackground And Objectives: Kidney impairment of ANCA-associated vasculitides can lead to kidney failure. Patients with kidney failure may suffer from vasculitis relapses but are also at high risk of infections and cardiovascular events, which questions the maintenance of immunosuppressive therapy.
Design, Setting, Participants, & Measurements: Patients with ANCA-associated vasculitides initiating long-term dialysis between 2008 and 2012 in France registered in the national Renal Epidemiology and Information Network registry and paired with the National Health System database were included.